About Us

The RenalPro™ System stands out for its simple, elegant technology: ideal for kidney preservation and AKI prevention.

CardioRenal Systems is a medical device company that is developing and marketing an exciting clinically proven CE-approved solution that has prevented acute kidney injury (AKI) in multiple clinical settings including cardiac surgery, heart catheterization procedures, and patients admitted to the ICU.

Our mission is to help improve morbidity and mortality rates, preserve quality of life, and reduce healthcare costs with our proprietary, IP-rich innovations currently protected by 20 patents and patent pending applications.

Management Team

Our visionary management team drives innovation and excellence, steering the company toward growth and success

Decade of experience guiding strategic product and business development. Managing Partner at Imagine Bio, a strategic consultancy that supported innovation strategy at clients such as JNJ and Boehringer Ingelheim. Former CEO at NeuroQuest. Studied finance and biochemistry at Miami Univ. of Ohio.

Ilya Budik

CEO

Ethan Benovitz Chairman HQ Standing December 12 cropped-Photoroom

Ethan Benovitz is a seasoned investor with more than 25 years of experience investing in the healthcare and technology sectors. He began his career as a corporate attorney after earning his JD from Harvard Law School. Ethan’s expertise in strategy, corporate finance and governance make him a trusted advisor to a variety of corporations and executives.

Ethan Benovitz, JD

Chairman

Cardiothoracic surgeon with 25+ years of clinical experience in UK and UAE. Involved in clinical validation of three emerging medical technologies including RenalGuard’s UK validation study in CSA-AKI. Author of 137 peer-reviewed publications.

Heyman Luckraz, FRCS, MD

SVP Medical Affairs

Laura Dern

President

18 years of experience managing clinical and regulatory affairs at emerging medtech companies, including dozens of clinical trials as well as FDA, CE, and Japanese approvals at Nucleix, Oridian (acq. by Medtronic), and Brainsway (NASDAQ: BWAY).

Shmulik Adler

SVP Clinical & Regulatory Affairs

Former Chief Medical Officer at Covidien, GE Healthcare, and Cheetah Medical (acq. by Baxter for $238 million). Practicing anesthesiologist at Harvard’s Mass General Hospital.

William “Pepper” Denman, MD

Sr. Medical & Industry Advisor

Partner at Hogan Lovells. Extensively recognized as leading regulatory advisor with over 25 years of experience guiding dozens of innovative devices through successful FDA approvals. BS mechanical engineering at MIT, JD Georgetown.

Janice Hogan, JD

Sr. Regulatory Advisor

40+ years of experience in medical device sales in US, EMEA, and APAC regions. Led Acist sales launch through growth and post-acquisition to Bracco. Track record of international expansion, distribution management, and channel marketing.

Robin Luper,

SVP Sales, International

20+ years experience managing finance in tech and biotech companies including taking Regenocell Labs public on Nasdaq, acquisition of Magnifire by F5 Networks, and company financings totaling over $100 million. Formerly senior accountant at KPMG. BA Accounting from York Univ.

Tzvi Stern,CPA

CFO

Manages business development and operations projects. Previously served as a Sr. Analyst of healthcare innovation at Imagine Bio. He worked for Healthcare Solutions. Studied Biology at Northland College in Wisconsin.

Avi Wise

Dir. of Business Operations

A Biomedical Engineer with experience in service operations and technical product support across Dräger, Edwards Lifesciences, and Becton Dickinson. Fluent in English, German, and Polish, he combines strong technical expertise with customer-focused solutions in healthcare technology. Master’s degree in Biomedical Engineering

Tobiasz Lepiarczyk

Dir. of Service Operations, EMEA

Scientific Advisory Board

Our esteemed Scientific Advisory Board is actively involved in providing guidance and conducting clinical studies at their centers, ensuring real-world expertise and insight.

Prof. of Nephrology at Univ. of Vermont. Leading KOL in field of AKI and principal investigator for numerous important trials. Member of the NIH consortium for AKI biomarkers.

Richard Solomon, MD

Nephrologist, University of Vermont

Practicing anesthesiologist and professor with extensive clinical research focused on best practices in perioperative medicine including prevention of acute kidney injury in cardiac surgery patients.

JACOB RAPHAEL, MD, FAHA

Anesthesiologist, Thomas Jefferson Univ. Hospital

Cardiothoracic Surgeon and Medical Director of Heart, Vascular and Critical Care Unit at Baystate Medical Center. Head of ERAS (Enhanced Recovery After Surgery) Society.

Dan Engelman, MD

Cardiothoracic Surgeon, Head of ERAS Society

Chair, Department of Surgery at Baylor College of Medicine and Texas Heart Institute. KOL with extensive clinical research and publications in Cardiac Surgery and CSA-AKI.

Todd Rosengart, MD, FACS

Cardiothoracic Surgeon, Baylor College of Medicine

Cardiothoracic surgeon and physician leader, with over three decades of experience. Educated at Ohio State, specializing in complex heart surgeries, including valve repair and aortic aneurysm treatment.

VICTOR SCHMELZER, MD

Cardiovascular Surgeon, St. Elizabeth Healthcare